Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Inhibition of transcription by adriamycin is a consequence of the loss of negative superhelicity in DNA mediated by topoisomerase II.
Tarr M
,
van Helden PD
.
???displayArticle.abstract???
Adriamycin is commonly used as a chemotherapeutic agent and is known to intercalate into the major groove of DNA and inhibit DNA and RNA synthesis. Results presented in this communication suggest that adriamycin affects topoisomerase cleavage of DNA. The resultant change in negative superhelicity (decrease) is responsible for the decrease in transcription. This process is not dependent on the continued presence of adriamycin. The reaction between topoisomerases, DNA and adriamycin is dose-dependent. The results help to explain the relatively enhanced cytotoxicity of this drug to tumor cells.
Bertrand-Burggraf,
Effect of superhelicity on the transcription from the tet promoter of pBR322. Abortive initiation and unwinding experiments.
1984, Pubmed
Bertrand-Burggraf,
Effect of superhelicity on the transcription from the tet promoter of pBR322. Abortive initiation and unwinding experiments.
1984,
Pubmed
Brill,
Need for DNA topoisomerase activity as a swivel for DNA replication for transcription of ribosomal RNA.
,
Pubmed
Chaires,
Daunomycin inhibits the B leads to Z transition in poly d(G-C).
1983,
Pubmed
Drlica,
Inhibitors of DNA topoisomerases.
1988,
Pubmed
Glikin,
Chromatin assembly in Xenopus oocytes: in vitro studies.
1984,
Pubmed
,
Xenbase
Heck,
Topoisomerase II: A specific marker for cell proliferation.
1986,
Pubmed
Kubo,
In vivo enhancement of general and specific transcription in Escherichia coli by DNA gyrase activity.
1979,
Pubmed
Nelson,
Growth-related elevations of DNA topoisomerase II levels found in Dunning R3327 rat prostatic adenocarcinomas.
1987,
Pubmed
Pommier,
Effects of DNA intercalating agents on topoisomerase II induced DNA strand cleavage in isolated mammalian cell nuclei.
1985,
Pubmed
Pommier,
Effects of the DNA intercalators 4'-(9-acridinylamino)methanesulfon-m-anisidide and 2-methyl-9-hydroxyellipticinium on topoisomerase II mediated DNA strand cleavage and strand passage.
1985,
Pubmed
Ryoji,
Chromatin assembly in Xenopus oocytes: in vivo studies.
1984,
Pubmed
,
Xenbase
Spadari,
DNA polymerases and DNA topoisomerases as targets for the development of anticancer drugs.
1986,
Pubmed
Stirdivant,
DNA supercoiling affects in vitro transcription of two maize chloroplast genes differently.
1985,
Pubmed
Tewey,
Adriamycin-induced DNA damage mediated by mammalian DNA topoisomerase II.
1984,
Pubmed
Thompson,
Purification of nucleic acids by RPC-5 ANALOG chromatography: peristaltic and gravity-flow applications.
1983,
Pubmed
Van Helden,
Effects of adriamycin on heart and skeletal muscle chromatin.
1982,
Pubmed
Van Helden,
The effect of adriamycin on Z-DNA formation and DNA synthesis.
1983,
Pubmed
Wang,
Recent studies of DNA topoisomerases.
1987,
Pubmed
Wells,
Unusual DNA structures.
1988,
Pubmed
Zähringer,
Decrease of myocardial mRNA in adriamycin-treated rats.
1981,
Pubmed
Zähringer,
Effect of adriamycin on the polyribosome and messenger-RNA content of rat heart muscle.
1980,
Pubmed